Hidden Fee Disclosure Act of 2023
Summary
The Hidden Fee Disclosure Act of 2023 aims to increase transparency in healthcare costs by requiring pharmacy benefit managers (PBMs) and third-party administrators to disclose the compensation they receive for managing employer-sponsored health plans. By mandating the disclosure of direct and indirect fees, the bill seeks to ensure that employers and employees can see the true cost of prescription drugs and how middlemen are being paid. The practical impact for citizens would be a clearer understanding of why their medications cost what they do, potentially leading to lower premiums and out-of-pocket expenses as hidden fees are brought to light.
AI-generated summary
Lifecycle of the Bill
Introduced in House
Jul 17, 2025
Introduced in House
Jul 17, 2025
Referred to the Committee on House Administration, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 17, 2025
Referred to the Committee on House Administration, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 17, 2025
